These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26611885)

  • 1. Not low hanging but still sweet: Metabolic proteomes in cardiovascular disease.
    Monte E; Lopez R; Vondriska TM
    J Mol Cell Cardiol; 2016 Jan; 90():70-3. PubMed ID: 26611885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the cardiac succinylome and its role in ischemia-reperfusion injury.
    Boylston JA; Sun J; Chen Y; Gucek M; Sack MN; Murphy E
    J Mol Cell Cardiol; 2015 Nov; 88():73-81. PubMed ID: 26388266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic profiling of the heart during acute ischemic preconditioning reveals a role for SIRT1 in rapid cardioprotective metabolic adaptation.
    Nadtochiy SM; Urciuoli W; Zhang J; Schafer X; Munger J; Brookes PS
    J Mol Cell Cardiol; 2015 Nov; 88():64-72. PubMed ID: 26388263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental diabetes mellitus exacerbates ischemia/reperfusion-induced myocardial injury by promoting mitochondrial fission: Role of down-regulation of myocardial Sirt1 and subsequent Akt/Drp1 interaction.
    Tao A; Xu X; Kvietys P; Kao R; Martin C; Rui T
    Int J Biochem Cell Biol; 2018 Dec; 105():94-103. PubMed ID: 30381241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Therapy with SS31 and Mitochondria Mitigates Myocardial Ischemia-Reperfusion Injury in Rats.
    Lee FY; Shao PL; Wallace CG; Chua S; Sung PH; Ko SF; Chai HT; Chung SY; Chen KH; Lu HI; Chen YL; Huang TH; Sheu JJ; Yip HK
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic disarrangement in ischemic heart disease and its therapeutic control.
    Ferrari R
    Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postischemic administration of succinate reverses the impairment of oxidative phosphorylation after cardiac ischemia and reperfusion injury.
    Cairns CB; Ferroggiaro AA; Walther JM; Harken AH; Banerjee A
    Circulation; 1997 Nov; 96(9 Suppl):II-260-5. PubMed ID: 9386108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic adaptation to a disruption in oxygen supply during myocardial ischemia and reperfusion is underpinned by temporal and quantitative changes in the cardiac proteome.
    Li X; Arslan F; Ren Y; Adav SS; Poh KK; Sorokin V; Lee CN; de Kleijn D; Lim SK; Sze SK
    J Proteome Res; 2012 Apr; 11(4):2331-46. PubMed ID: 22352837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria respiration and susceptibility to ischemia-reperfusion injury in diabetic hearts.
    Lashin O; Romani A
    Arch Biochem Biophys; 2003 Dec; 420(2):298-304. PubMed ID: 14654069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury.
    Wischmeyer PE; Jayakar D; Williams U; Singleton KD; Riehm J; Bacha EA; Jeevanandam V; Christians U; Serkova N
    JPEN J Parenter Enteral Nutr; 2003; 27(6):396-403. PubMed ID: 14621120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix proteomics in cardiac ischemia/reperfusion: the search is on.
    Deleon KY; de Castro Brás LE; Lange RA; Lindsey ML
    Circulation; 2012 Feb; 125(6):746-8. PubMed ID: 22261193
    [No Abstract]   [Full Text] [Related]  

  • 12. Proteomic analysis of right and left cardiac ventricles under aerobic conditions and after ischemia/reperfusion.
    Cadete VJ; Lin HB; Sawicka J; Wozniak M; Sawicki G
    Proteomics; 2012 Aug; 12(14):2366-77. PubMed ID: 22685060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of farnesoid-X-receptor SUMOylation mutation on myocardial ischemia/reperfusion injury in mice.
    Gao Y; Zhao Y; Yuan A; Xu L; Huang X; Su Y; Gao L; Ji Q; Pu J; He B
    Exp Cell Res; 2018 Oct; 371(2):301-310. PubMed ID: 30098335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial fatty acid oxidation during ischemia and reperfusion.
    Lerch R; Tamm C; Papageorgiou I; Benzi RH
    Mol Cell Biochem; 1992 Oct; 116(1-2):103-9. PubMed ID: 1282666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure.
    Lesnefsky EJ; Moghaddas S; Tandler B; Kerner J; Hoppel CL
    J Mol Cell Cardiol; 2001 Jun; 33(6):1065-89. PubMed ID: 11444914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose calcium antagonists reduce energy demand and cellular damage of isolated hearts during both ischemia and reperfusion.
    Becker BF; Möbert J
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):287-94. PubMed ID: 10543430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophilin D and myocardial ischemia-reperfusion injury: a fresh perspective.
    Alam MR; Baetz D; Ovize M
    J Mol Cell Cardiol; 2015 Jan; 78():80-9. PubMed ID: 25281838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT1 as a Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury and Cardiometabolic Disease.
    Han D; Wang J; Ma S; Chen Y; Cao F
    Curr Drug Targets; 2017; 18(15):1746-1753. PubMed ID: 26122034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of leptin levels in serum and myocardium after myocardial ischemia/reperfusion injury].
    Xue H; Yan GT; Lin J; Hao XH; Zhang K
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 May; 25(2):221-3. PubMed ID: 21189557
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.